|Proximal protection in recanalization of totally occluded saphenous vein grafts in acute coronary syndrome.|
|PMID: 20146345 Owner: NLM Status: MEDLINE|
|Percutaneous treatment of old, degenerated saphenous vein grafts (SVG) is associated with a high likelihood of major adverse cardiac events. When an acute coronary syndrome (ACS) develops in a patient with old SVG, fresh thrombus may superimpose on an old, degenerative atheroma: a sudden increase in the athero-thrombotic burden ensues with consequent, frequent total occlusion of the lumen. In this scenario, transluminal recanalization of the graft is usually associated with the highest chance of distal embolization and no-reflow and positioning of an embolic protection device (EPD) is almost mandatory. However, distal EPD are difficult to place when the vessel is totally occluded and do not completely avoid distal embolization. We report two cases of totally occluded SVG in patients admitted for ACS that were recanalized with the aid of a proximal EPD system with angiographic and clinical success.|
|Paolo Sganzerla; Emanuela Tavasci|
Related Documents :
|7149975 - In situ saphenous vein bypass.
11573835 - Aneurysms and pseudoaneurysms of coronary arteries and saphenous vein coronary artery b...
18942125 - Percutaneous saphenous vein graft intervention with sequential embolic protection devic...
18363615 - Hepatic artery reconstruction with inferior mesenteric vein graft in pediatric living d...
18402795 - Surgical pathology of 104 tricuspid valves (2000-2005) with classic right-sided ebstein...
11769155 - Retroesophageal subclavian artery aneurysm arising from kommerell's diverticulum.
|Type: Case Reports; Journal Article|
|Title: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions Volume: 75 ISSN: 1522-726X ISO Abbreviation: Catheter Cardiovasc Interv Publication Date: 2010 Jun|
|Created Date: 2010-06-02 Completed Date: 2010-09-07 Revised Date: -|
Medline Journal Info:
|Nlm Unique ID: 100884139 Medline TA: Catheter Cardiovasc Interv Country: United States|
|Languages: eng Pagination: 1051-5 Citation Subset: IM|
|Division of Cardiology, Humanitas Gavazzeni, Bergamo, Italy. email@example.com|
|APA/MLA Format Download EndNote Download BibTex|
Acute Coronary Syndrome
Angioplasty, Transluminal, Percutaneous Coronary* / adverse effects, instrumentation
Cardiovascular Agents / administration & dosage
Coronary Artery Bypass / adverse effects*
Embolism / etiology, prevention & control
Filtration / instrumentation
Graft Occlusion, Vascular / etiology, physiopathology, radiography, therapy*
Saphenous Vein / physiopathology, radiography, transplantation*
Sirolimus / administration & dosage, analogs & derivatives
Thrombosis / etiology, physiopathology, radiography, therapy*
|0/Cardiovascular Agents; 0/Metals; 159351-69-6/everolimus; 53123-88-9/Sirolimus|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Pathologic evaluation of sentinel lymph nodes in oral squamous cell carcinoma.
Next Document: Leptin-like immunoreactivity in the muscle of juvenile sea bass (Dicentrarchus labrax).